Training Induced Muscle-Adipose EV Communication
TIMER2
Muscle-derived Extracellular Vesicles and Their Interactions With Adipocytes in Human Metabolic Dysfunction
2 other identifiers
interventional
80
1 country
1
Brief Summary
This study examines how muscle cells communicate with fat cells through tiny packages called extracellular vesicles (EV) during exercise. These vesicles carry important molecules that may affect how the body processes sugar and fat. The research team observed significant variability in the adipose response to exercise, and used this variability to gain further insight into the mechanism through which mature microRNA-1 (miR-1) changes in adipose tissue. The investigators selected six subjects with the highest increase in miR-1 abundance in adipose tissue after exercise and compared them with the six subjects that had the most dramatic decrease in miR-1 abundance after exercise. The research team observed that participants intrinsically vary in their ability to endocytose EV into adipose tissue. It is unclear whether this variance in receptivity is a cause or consequence of the significant difference in EV-delivery of miR-1 to adipose tissue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2025
CompletedFirst Posted
Study publicly available on registry
August 6, 2025
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2028
Study Completion
Last participant's last visit for all outcomes
September 30, 2028
March 23, 2026
December 1, 2025
2.3 years
July 22, 2025
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
miR-1 abundance in adipose tissue
Quantification of mature microRNA-1 levels in subcutaneous adipose tissue biopsies using quantitative Real Time-PCR as validated biomarker of in vivo extracellular vesicle uptake
60 minutes post-exercise (single measurement)
Extracellular vesicle uptake capacity in primary adipocytes
Measurement of fluorescently-labeled extracellular vesicle internalization in cultured primary adipocytes using confocal microscopy to quantify uptake rates in units of vesicles per minute per cell.
24-48 hours post-isolation (in vitro culture)
Secondary Outcomes (4)
Serum extracellular vesicle miR-1 content
Baseline, 0, 30, 60, and 90 minutes post-exercise
Adipose tissue transcriptomic signatures
60 minutes post-exercise (single measurement)
Adrenergic receptor gene expression in adipose tissue
60 minutes post-exercise (single measurement)
Primary muscle miR-1 transcript levels
60 minutes post-exercise (single measurement)
Other Outcomes (3)
Extracellular vesicle tetraspanin marker profiles using ExoView platform
Baseline and 90 minutes post-exercise
Circulating extracellular vesicle count using ExoView single vesicle analysis platform
Baseline and 90 minutes post-exercise
Extracellular vesicle size distribution using ExoView single vesicle analysis
Baseline and 90 minutes post-exercise
Study Arms (1)
Acute Resistance Exercise
EXPERIMENTALParticipants will perform four exercises: squat, knee extension, leg press, and lat pulldown at 80% of 1-RM (repetition maximum) determined during a previous visit.
Interventions
Participants will perform three sets of eight repetitions, with a 90-120 second rest between sets, with a fourth set performed to failure. All resistance exercise will be performed on pneumatic resistance devices (Keiser Sports Health Equipment, Fresno, CA).
Eligibility Criteria
You may qualify if:
- Age 30-55 years
- Sedentary lifestyle (exercise \<1 day/week for at least 3 months prior to enrollment)
- Able to provide informed consent
- For Control Group: BMI \< 27 kg/m², normal glucose tolerance, no more than 1 feature of metabolic syndrome
- For Prediabetic Group: BMI \> 30 kg/m², at least 3 features of metabolic syndrome including prediabetes (defined as fasting plasma glucose 100-125 mg/dL OR 2-hour post-load glucose on 75g OGTT 140-199 mg/dL OR HbA1C 5.7-6.4%)
You may not qualify if:
- Pregnancy (confirmed by pregnancy test in women of childbearing potential)
- Type 2 diabetes mellitus
- Cardiovascular contraindications to resistance exercise
- Medical conditions that would interfere with muscle or adipose tissue biopsy procedures
- Use of medications that significantly affect glucose metabolism or exercise response
- Active participation in structured exercise programs (\>1 day/week) within 3 months of enrollment
- Inability to safely participate in resistance exercise protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yuan Wenlead
- National Institute of General Medical Sciences (NIGMS)collaborator
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40506, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yuan Wen, MD, PhD
University of Kentucky
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 22, 2025
First Posted
August 6, 2025
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
September 30, 2028
Last Updated
March 23, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to protect participant privacy and confidentiality. Summary results and findings will be made available through peer-reviewed publications and presentation at scientific conferences.